NCT02272517View on ClinicalTrials.gov

Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Major Depressive Disorder
Interventions
DRUG

Vortioxetine 10-20 mg

DRUG

Escitalopram 10-20 mg

Trial Locations (16)

Unknown

FI005, Helsinki

FI001, Kuopio

FI006, Kupio

FI007, Tampere

FI004, Turku

DE005, Bochum

DE004, Mittweida

RS002, Belgrade

RS003, Belgrade

RS004, Belgrade

RS005, Belgrade

RS001, Kragujevac

SK004, Bratislava

SK001, Domaša

SK003, Levice

SK002, Rimavská Sobota

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT02272517 - Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder | Biotech Hunter | Biotech Hunter